Company: Pinewood Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Losartan (K+) 50mg, 100mg. Description: Resp. round or oval, white, convex, film-coated tablets. 50mg scored on one side, can be broken into equal halves. Presentation: 50mg, €13.80; 100mg, €23.20. Indications: Treatment of hypertension. Reduction in the risk of stroke in hypertensive patients with left [...]
Mirtall
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Mirtazapine 15mg, 30mg, 45mg. Description: Resp. yellow, brownish or white, oval, biconvex film-coated tablets. 15mg, 30mg: Scored. 45mg: Marked I. Presentation: 15mg-30; 30mg-30; 45mg-30. Prices on request. Indication: Major depressive episodes. Pharmacology: Mirtazapine is a presynaptic α2-antagonist, which increases noradrenergic and serotonergic neurotransmission [...]
Multaq
Company: sanofi-aventis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Dronedarone (HCl) 400mg. Description: White, oblong shaped film-coated tablets, engraved with a double wave marking on one side and 4142 on the other. Presentation: 60, €73.20. Indication: Prevention of recurrence of atrial fibrillation (AF) or to lower ventricular rate in clinically stable adults [...]
Solvatan
Company: Helsinn Birex Therapeutics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Losartan (K+) 50mg, 100mg. Description: 50mg: White, round, biconvex, scored, film-coated tablets, embossed with 3L on one side. 100mg: White, oval, biconvex, scored, film-coated tablets, embossed with 4L on one side. Presentation: 50mg-28, €13.28; 100mg-28, €22.33. Indications: Hypertension. Reduction in the risk [...]
New oral administration route for Konakion MM Ampoules 10mg/ml Solution for Injection
Roche Products (Ireland) Ltd are pleased to advise that the application to register an oral route of administration for the Konakion MM Ampoules 10mg/ml presentation has been approved by the Irish Medicines Board. This new oral administration route has been developed following the recent discontinuation of Konakion 10mg tablets to reduce the patient impact of [...]